sumatriptan has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dichgans, J; Diener, HC; Ehrmann, R; Haux, R; Noe, A; Peters, C; Rudzio, M; Tfelt-Hansen, P | 1 |
| Bolden-Watson, CP; Davis, RL; Fox, AW; Gutterman, DL; O'Quinn, S; Putnam, GP | 1 |
2 other study(ies) available for sumatriptan and cardiovascular agents
| Article | Year |
|---|---|
Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs.
Topics: Adult; Blood Flow Velocity; Cardiovascular Agents; Cerebrovascular Circulation; Ergotamine; Female; Flunarizine; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Reference Values; Sulfonamides; Sumatriptan; Vasoconstrictor Agents | 1991 |
Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anti-Asthmatic Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents; Cardiovascular Agents; Cohort Studies; Comorbidity; Contraceptives, Oral, Hormonal; Depression; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Hypnotics and Sedatives; Injections, Subcutaneous; Male; Methysergide; Middle Aged; Migraine Disorders; Patient Acceptance of Health Care; Prospective Studies; Serotonin Receptor Agonists; Smoking; Sumatriptan; Valproic Acid; Vasoconstrictor Agents | 1999 |